Tech Company Financing Transactions

CellsBin Funding Round

CellsBin closed a Series A funding round on 9/22/2026. Investors included 108 BioCapital and private investors.

Transaction Overview

Company Name
Announced On
9/22/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors

108 BioCapital (Lead Investor)

Proceeds Purpose
The company intends to use the funds to accelerate commercialization, strategic partnerships, product development and expansion of its clinical and technical capabilities.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
101 College St
New Haven, CT 06510
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
CellsBin is a technology-bio company combining photonics, AI, and translational science to make rare cells visible and turn them into actionable clinical insight. Clinicians still lack a reliable way to detect and understand the rare cells that can determine disease progression, treatment response, and relapse--limiting their ability to act early and with confidence. We believe Rare-Cell Biology� is a foundational layer of precision medicine: when low-abundance cells become visible, measurable, and biologically understood, their signals can be translated into actionable clinical decisions that improve how medicine treats patients.
Profile
CellsBin LinkedIn Company Profile
Social Media
CellsBin Company Twitter Account
Company News
CellsBin News
Facebook
CellsBin on Facebook
YouTube
CellsBin on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ali Kabiri
  Ali Kabiri LinkedIn Profile  Ali Kabiri Twitter Account  Ali Kabiri News  Ali Kabiri on Facebook
Chief Medical Officer
Sajad Salehi
  Sajad Salehi LinkedIn Profile  Sajad Salehi Twitter Account  Sajad Salehi News  Sajad Salehi on Facebook
Chief Technical Officer
Rebecca MacLeod
  Rebecca MacLeod LinkedIn Profile  Rebecca MacLeod Twitter Account  Rebecca MacLeod News  Rebecca MacLeod on Facebook
Chief Technical Officer
Nima Sarshar
  Nima Sarshar LinkedIn Profile  Nima Sarshar Twitter Account  Nima Sarshar News  Nima Sarshar on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/22/2026: Primo venture capital transaction
Next: 9/22/2026: Zeliq venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary